F. Hoffmann-La Roche Ltd - Digital Transformation Strategies

F. Hoffmann-La Roche Ltd (Roche) is a healthcare company that develops drugs and diagnostics devices for treating diseases. It provides medicines and diagnostics for oncology, immunology, neuroscience, ophthalmology, infectious diseases, respiratory, and other areas. The company also provides in-vitro diagnostics, tissue-based cancer diagnostics, and diabetes management solutions. The company offers its products and services to hospitals, commercial laboratories, healthcare professionals, researchers, and pharmacists. In 2021, pharmaceuticals accounted for the major share of the company’s revenue.

This report provides insight into Roche's technology activities, including:

Insights into its digital transformation strategies and accelerator/incubator and other innovation programs.

Overview of technology initiatives covering partnerships, product launches, investments and acquisitions.

Insights on each technology initiative including technology theme, objective, and benefits.
Details of estimated ICT budgets and major ICT contracts.

Scope

- Roche is exploring and utilizing technologies including artificial intelligence, cloud, big data, blockchain, and quantum computing to achieve operational efficiency and launch innovative products.
- Roche has invested in healthtech companies that are using machine learning tools to accelerate diagnosis of cancer and discover biomarkers.
- Roche recently acquired Flatiron Health and Viewics

Reasons to Buy

- Gain insights into Roche's technology activties.
- Gain insights into its digital transformation strategies and innovation initiatives.
- Gain insights into its technology themes under focus.
- Gain insights into its various product launches, partnerships, investment and acquisition strategies.